OrbusNeich Medical Group Holdings Limited (HKG:6929)
Hong Kong · Delayed Price · Currency is HKD 3.770
-0.100 (-2.58%)
Jan 21, 2026, 3:00 PM HKT
HKG:6929 Market Cap
HKG:6929 has a market cap or net worth of 3.19 billion as of January 20, 2026. Its market cap has decreased by -0.75% in one year.
Market Cap
3.19B
Enterprise Value
1.28B
Revenue
1.32B
Ranking
n/a
PE Ratio
10.00
Stock Price
3.77
Market Cap Chart
Since December 23, 2022, HKG:6929's market cap has decreased from 7.57B to 3.19B, a decrease of -57.91%. That is a compound annual growth rate of -24.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 3.19B | 6.91% |
| Dec 31, 2025 | 2.98B | -3.69% |
| Dec 31, 2024 | 3.10B | -46.95% |
| Dec 29, 2023 | 5.84B | -19.87% |
| Dec 30, 2022 | 7.28B | -3.83% |
| Dec 23, 2022 | 7.57B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.88B |
| Hansoh Pharmaceutical Group Company | 249.91B |
| JD Health International | 212.13B |
| WuXi Biologics | 156.50B |
| Innovent Biologics | 148.05B |
| Sino Biopharmaceutical | 116.56B |
| CSPC Pharmaceutical Group | 111.36B |
| Akeso | 108.05B |